Urteste S.A. Stock

Equities

URT

PLURTST00010

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:55 2024-05-07 am EDT 5-day change 1st Jan Change
97.8 PLN 0.00% Intraday chart for Urteste S.A. 0.00% -10.28%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2020 - Sales 2021 - Capitalization 109M 438M
Net income 2020 -1M -4.01M Net income 2021 -2M -8.02M EV / Sales 2020 * -
Net cash position 2020 427K 1.71M Net cash position 2021 8.53M 34.21M EV / Sales 2021 -
P/E ratio 2020 *
-
P/E ratio 2021
-47.1 x
Employees 1
Yield 2020 *
-
Yield 2021
-
Free-Float 27.21%
More Fundamentals * Assessed data
Dynamic Chart
1 month-0.20%
3 months-7.74%
6 months-5.96%
Current year-10.28%
More quotes
1 week
94.00
Extreme 94
98.00
1 month
92.00
Extreme 92
112.50
Current year
85.00
Extreme 85
112.50
1 year
81.00
Extreme 81
138.00
3 years
70.40
Extreme 70.4
191.00
5 years
70.40
Extreme 70.4
191.00
10 years
70.40
Extreme 70.4
191.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 21-02-15
Corporate Officer/Principal 54 21-02-15
Members of the board TitleAgeSince
Director/Board Member 57 22-06-28
Director/Board Member 40 21-04-25
Director/Board Member 45 21-04-25
More insiders
Date Price Change Volume
24-05-07 97.8 0.00% 131
24-05-06 97.8 -0.20% 122
24-05-02 98 +0.20% 22
24-04-30 97.8 0.00% 2

Delayed Quote Warsaw S.E., May 07, 2024 at 11:55 am EDT

More quotes
Urteste SA is a Poland-based company mainly engaged in the biotechnology sector. The Company operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detection of cancer by measuring the activity of enzymes in a urine sample, using diagnostic tests that enable the detection of common cancers in their early stages. The Company offers tests for the detection of cancers such as, pancreatic cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, liver cancer, biliary tract cancer, stomach cancer, esophageal cancer, ovarian cancer, endometrial cancer, breast cancer, leukemia, lymphoma, glioma.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW